Worse disease-free survival in never-smokers with ALK+ lung adenocarcinoma

INTRODUCTION: The EML4–anaplastic lymphoma kinase (ALK) translocation is a recognized oncogenic driver in non-small cell lung cancer. We investigated immunohistochemistry (IHC) screening with fluorescence in-situ hybridization (FISH) confirmation for ALK detection and estimated the prevalence of ALK...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Yang, Ping, Kulig, Kimary, Boland, Jennifer M, Erickson-Johnson, Michele R, Oliveira, Andre M, Wampfler, Jason, Jatoi, Aminah, Deschamps, Claude, Marks, Randolph, Fortner, Connie, Stoddard, Shawn, Nichols, Francis, Molina, Julian, Aubry, Marie-Christine, Tang, Hui, Yi, Eunhee S
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3931519/
https://ncbi.nlm.nih.gov/pubmed/22134072
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0b013e31823c5c32
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars